REstoring Flow by REvascularization With Submaximal Angioplasty in Hemodynamic IntraCranial Atherosclerotic Stenosis

Part of paid clinical trials in Cleveland, Ohio.

Sponsor
Case Western Reserve University
Study ID
NCT03729817
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Angioplasty, Balloon
  • Device Safety
  • Hemodynamics
  • Intracranial Atherosclerotic Disease
  • Stroke

Eligibility Criteria

Sex
ALL
Age
30 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • Submaximal balloon angioplasty — DEVICE
    An endovascular procedure involving inflation of a balloon catheter undersized to 50-75% of normal vessel diameter to perform angioplasty of a stenotic blood vessel segment, with the goal of increasing blood flow.

Study Details

By assessing the safety and durability of an endovascular intervention, this study will justify and inform the design of a subsequent seamless feasibility/pivotal trial aimed at the treatment of intracranial atherosclerotic stenosis (ICAS), an entity which carries a high risk of stroke despite existing medical therapies, and has no other treatment options. Given the global burden of ICAS as a leading cause of stroke, there is a high potential for public health impact not just in the U.S., but world-wide.

Key Dates

Start date
Oct 31, 2027
Status verified
Nov 2025
Primary completion
Oct 31, 2031
Completion
Oct 31, 2032

Study Design

Enrollment
159 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Submaximal balloon angioplasty plus intensive medical therapy
    Endovascular intervention with submaximal balloon angioplasty

Primary Outcome Measure

Procedural Safety [ Time Frame: 30 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Case Western Reserve UniversityClevelandOhio44106
Sepideh Amin-Hanjani, MD
216-286-8945

Find similar trials in Cleveland, OH

By condition

Related Studies